• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丁苯那嗪,一种耗竭胺类的药物,也能阻断大鼠脑中的多巴胺受体。

Tetrabenazine, an amine-depleting drug, also blocks dopamine receptors in rat brain.

作者信息

Reches A, Burke R E, Kuhn C M, Hassan M N, Jackson V R, Fahn S

出版信息

J Pharmacol Exp Ther. 1983 Jun;225(3):515-21.

PMID:6864517
Abstract

Tetrabenazine (TBZ) is used in the treatment of hyperkinetic movement disorders. Its effect is thought to be mediated by depletion of dopamine (DA) stores. We studied other possible mechanisms of action of this drug. TBZ decreased DA concentration in rat striatum and nucleus accumbens in a dose-dependent manner with an IC50 of approximately 1.2 mg.kg-1. Maximal depletion was obtained within 30 min with only partial recovery at 8 hr. TBZ induced (at 40 mg . kg-1) 5- to 8-fold increases in 3,4-dihydroxyphenylacetic acid and homovanillic acid concentrations in both brain regions. Unlike reserpine, TBZ completely abolished the apomorphine-induced inhibition of DA synthesis under conditions in which this effect is mediated by presynaptic DA receptors. Both TBZ (5 mg . kg-1) and reserpine (5 mg . kg-1) depleted, at 1 hr, striatal DA content by approximately 90%. However, TBZ, but not reserpine, significantly stimulated in vivo tyrosine hydroxylase activity. TBZ also inhibited [3H]spiperone binding in the striatum with Ki = 2.1 X 10(-6) M. In rats, with unilateral destruction of the nigrostriatal pathway with 6-hydroxydopamine, pretreatment with TBZ significantly reduced the number of rotations induced by apomorphine. Finally, in rats treated with either TBZ (5 mg . kg-1) or reserpine (5 mg . kg-1), prolactin levels significantly increased as compared to control values. TBZ, but not reserpine, blocked apomorphine inhibition of prolactin secretion. We conclude that, in addition to depleting monoamines, TBZ also blocks both presynaptic and postsynaptic DA receptors in rat brain.

摘要

丁苯那嗪(TBZ)用于治疗运动亢进性运动障碍。其作用被认为是通过耗尽多巴胺(DA)储存来介导的。我们研究了这种药物其他可能的作用机制。TBZ以剂量依赖性方式降低大鼠纹状体和伏隔核中的DA浓度,IC50约为1.2mg·kg-1。在30分钟内可获得最大耗竭,8小时时仅有部分恢复。TBZ(40mg·kg-1)使两个脑区的3,4-二羟基苯乙酸和高香草酸浓度增加5至8倍。与利血平不同,在由突触前DA受体介导这种作用的条件下,TBZ完全消除了阿扑吗啡诱导的DA合成抑制。TBZ(5mg·kg-1)和利血平(5mg·kg-1)在1小时时均使纹状体DA含量耗尽约90%。然而,TBZ而非利血平显著刺激体内酪氨酸羟化酶活性。TBZ还抑制纹状体中[3H]螺哌隆结合,Ki = 2.1×10(-6)M。在大鼠中,用6-羟基多巴胺单侧破坏黑质纹状体通路后,用TBZ预处理可显著减少阿扑吗啡诱导的旋转次数。最后,在用TBZ(5mg·kg-1)或利血平(5mg·kg-1)治疗的大鼠中,催乳素水平与对照值相比显著升高。TBZ而非利血平阻断了阿扑吗啡对催乳素分泌的抑制。我们得出结论,除了耗尽单胺外,TBZ还阻断大鼠脑中的突触前和突触后DA受体。

相似文献

1
Tetrabenazine, an amine-depleting drug, also blocks dopamine receptors in rat brain.丁苯那嗪,一种耗竭胺类的药物,也能阻断大鼠脑中的多巴胺受体。
J Pharmacol Exp Ther. 1983 Jun;225(3):515-21.
2
Differential effects of reserpine and tetrabenazine on rat striatal synaptosomal dopamine biosynthesis and synaptosomal dopamine pools.利血平和丁苯那嗪对大鼠纹状体突触体多巴胺生物合成及突触体多巴胺池的不同作用。
J Pharmacol Exp Ther. 1977 May;201(2):357-67.
3
Presynaptic inhibition of dopamine synthesis in rat striatal tissue by enantiomeric mono- and dihydroxyaporphines.对映体单羟基和二羟基阿朴啡对大鼠纹状体组织中多巴胺合成的突触前抑制作用。
Mol Pharmacol. 1990 Jul;38(1):92-101.
4
Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.大鼠脑中与神经末梢及血小板相关的非5-羟色胺能[3H]酮色林结合位点的鉴定;与酮色林和丁苯那嗪类药物诱导的生物胺代谢产物释放的关系。
J Pharmacol Exp Ther. 1988 Jan;244(1):310-21.
5
Tetrabenazine has properties of a dopamine receptor antagonist.丁苯那嗪具有多巴胺受体拮抗剂的特性。
Ann Neurol. 1982 Sep;12(3):257-62. doi: 10.1002/ana.410120308.
6
Dopamine and neurotensin storage in colocalized and noncolocalized neuronal populations.
J Pharmacol Exp Ther. 1989 Jun;249(3):681-7.
7
Comparison of the acute actions of amine-depleting drugs and dopamine receptor antagonists on dopamine function in the brain in rats.大鼠脑中胺类消耗药物和多巴胺受体拮抗剂对多巴胺功能的急性作用比较。
Neuropharmacology. 1987 Feb-Mar;26(2-3):237-45. doi: 10.1016/0028-3908(87)90214-0.
8
Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo.内侧前额叶皮质中多巴胺合成的调节由释放调节自身受体介导:体内研究
J Pharmacol Exp Ther. 1986 Mar;236(3):689-98.
9
CI-1007, a dopamine partial agonist and potential antipsychotic agent. I. Neurochemical effects.CI - 1007,一种多巴胺部分激动剂及潜在的抗精神病药物。I. 神经化学效应。
J Pharmacol Exp Ther. 1995 Aug;274(2):898-911.
10
RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.RDS - 127(2 - 二正丙基氨基 - 4,7 - 二甲氧基茚满):一种新型多巴胺受体激动剂的中枢效应
J Pharmacol Exp Ther. 1983 Jan;224(1):161-70.

引用本文的文献

1
Protective Effects of Antcin H Isolated from Antrodia cinnamomea Against Neuroinflammation in Huntington's Disease via NLRP3 Inflammasome Inhibition.从樟芝中分离出的安替辛H通过抑制NLRP3炎性小体对亨廷顿舞蹈病神经炎症的保护作用
J Neuroimmune Pharmacol. 2024 Dec 2;20(1):1. doi: 10.1007/s11481-024-10161-7.
2
Neuroinflammation in Neurodegenerative Disorders: Current Knowledge and Therapeutic Implications.神经退行性疾病中的神经炎症:当前的认识和治疗意义。
Int J Mol Sci. 2024 Apr 3;25(7):3995. doi: 10.3390/ijms25073995.
3
Risk of Neuroleptic Malignant Syndrome with Vesicular Monoamine Transporter Inhibitors.
使用囊泡单胺转运体抑制剂引发神经阻滞剂恶性综合征的风险。
Clin Psychopharmacol Neurosci. 2020 May 31;18(2):322-326. doi: 10.9758/cpn.2020.18.2.322.
4
Tetrabenazine: Spotlight on Drug Review.丁苯那嗪:药物审评聚焦
Ann Neurosci. 2016 Sep;23(3):176-185. doi: 10.1159/000449184. Epub 2016 Sep 9.
5
Tetrabenazine-induced oculogyric crisis - a rare complication in the treatment of Gilles de la Tourette syndrome.丁苯那嗪诱发的动眼危象——一种治疗抽动秽语综合征时罕见的并发症。
Neuropsychiatr Dis Treat. 2016 Feb 25;12:497-9. doi: 10.2147/NDT.S98694. eCollection 2016.
6
Tetrabenazine: for chorea associated with Huntington's disease.四苯嗪:用于亨廷顿舞蹈病相关的舞蹈症。
CNS Drugs. 2011 Dec 1;25(12):1073-85. doi: 10.2165/11208330-000000000-00000.
7
Tetrabenazine inhibition of monoamine uptake and methamphetamine behavioral effects: locomotor activity, drug discrimination and self-administration.四苯嗪对单胺摄取的抑制作用及安非他命的行为效应:运动活动、药物辨别和自我给药。
Neuropharmacology. 2011 Sep;61(4):849-56. doi: 10.1016/j.neuropharm.2011.05.033. Epub 2011 Jun 12.
8
Management of Huntington's disease: role of tetrabenazine.亨廷顿病的治疗:四苯丁嗪的作用。
Ther Clin Risk Manag. 2011;7:123-9. doi: 10.2147/TCRM.S17152. Epub 2011 Mar 21.
9
Tetrabenazine (Xenazine), An FDA-Approved Treatment Option For Huntington's Disease-Related Chorea.丁苯那嗪(Xenazine),一种获美国食品药品监督管理局批准用于治疗亨廷顿舞蹈症相关舞蹈症的治疗选择。
P T. 2008 Dec;33(12):690-4.
10
Tetrabenazine in the treatment of Huntington's disease.四苯嗪治疗亨廷顿病。
Neuropsychiatr Dis Treat. 2007;3(5):545-51.